NCT06804928

Brief Summary

Effect of Virtual Reality Glasses on Pain, Anxiety, and Comfort During ESWL

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 28, 2025

Completed
4 days until next milestone

Study Start

First participant enrolled

February 1, 2025

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 3, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
Last Updated

June 11, 2026

Status Verified

November 1, 2025

Enrollment Period

7 months

First QC Date

January 28, 2025

Last Update Submit

June 9, 2026

Conditions

Outcome Measures

Primary Outcomes (7)

  • VAS

    Pain levels will be assessed.

    Data will be collected 10 minutes before the procedure.

  • Visual Anxiety Scale (VAS-A)

    Anxiety levels will be assessed.

    Data will be collected 10 minutes before the procedure.

  • Visual Comfort Scale

    Comfort levels will be assessed.

    Data will be collected 10 minutes before the procedure.

  • Spielberger Trait Anxiety Inventory (STAI-II)

    It will be used to measure trait anxiety levels before the procedure.

    The measurement will be conducted only once, 10 minutes before the procedure.

  • VAS

    Pain levels will be assessed.

    Data will be collected 30 minutes after the procedure.

  • Visual Anxiety Scale (VAS-A)

    Anxiety levels will be assessed.

    Data will be collected 30 minutes after the procedure.

  • Visual Comfort Scale

    Comfort levels will be assessed.

    Data will be collected 30 minutes after the procedure.

Study Arms (2)

VR-G (Virtual Reality Group) (1)

EXPERIMENTAL

During the procedure, the patient will wear virtual reality glasses and watch a video. The video will be played through the virtual reality glasses throughout the entire procedure.

Behavioral: Virtual Reality Glasses

Control Group (2)

NO INTERVENTION

No intervention will be applied to the patients in the control group, and the standard care protocol of the clinic will be followed.

Interventions

During the procedure, the patient will wear virtual reality glasses and watch a video. The video will be played through the virtual reality glasses throughout the entire procedure.

Also known as: Control group
VR-G (Virtual Reality Group) (1)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being 18 years of age or older, Having no hearing or perception impairments, Having no visual impairments, Undergoing ESWL for the first time.

You may not qualify if:

  • Use of any analgesic or anxiolytic medication before the procedure, Having a psychiatric disorder, The procedure being performed on an emergency basis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Samsun Gazi State Hospital

Samsun, Merkez, 55070, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Anxiety DisordersPain

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Mental DisordersNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The measurements will be conducted by an individual independent of the study. Additionally, the statistical analysis of the research will be performed by a statistician who is unaware of the study details. The randomization plan was also prepared by a researcher independent of the study.
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer Dr.

Study Record Dates

First Submitted

January 28, 2025

First Posted

February 3, 2025

Study Start

February 1, 2025

Primary Completion

September 1, 2025

Study Completion

September 1, 2025

Last Updated

June 11, 2026

Record last verified: 2025-11

Locations